Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.
Daniel E. Hilleman, PharmD, FCCP
Advertisement
Articles by Daniel E. Hilleman, PharmD, FCCP
This review summarizes the safety and efficacy of 3 new orally active anticoagulant drugs (dabigatran, rivaroxaban, apixaban) that can be used as alternatives to warfarin.
Advertisement
Latest Updated Articles
Hypertension: A Silent Killer Requiring Novel TherapiesJuly 19th 2025
- New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
December 11th 2012
Advertisement
Advertisement
Trending on Pharmacy Times
1
NK3 as a Drug Target: From Scientific Discovery to Guideline-Recognized Therapy
2
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
3
New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum
4
Sonrotoclax Plus Zanubrutinib Produces Deep MRD Responses in Treatment-Naive CLL
5